In accordance with 5 CFR 1320, the information collection is approved for 1 year. Upon resubmission to OMB, the agency must provide a summary of all comments made on the information collection and any changes made to the information collection. In addition, the agency should reduce redundant collection of information from principal investigators that share laboratory facilities and should reduce the burden associated with amending registrations by limiting the information required from respondents to the changes in the information.
Inventory as of this Action
Requested
Previously Approved
05/31/2007
05/31/2007
05/31/2004
10,382
0
15,853
17,905
0
35,204
0
0
0
CDC is promulgating new regulations concerning the possession, use, and transfer of select agents and toxins as an Interim Final Rule under 42 CFR Part 73. Under the new regulations, entities are required to follow measures designed to ensure the health and safety of their workers and the public. Entities must register with CDC; identify individuals who require access to these agents and toxins; train these individuals, establish safety, security, and emergency response plans; and maintain records of all such activities.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.